Why Recessions Forge Great CEOs Who Think Beyond Cost-Cutting
04/15/2025
No Comments
But the CEOs who make history in downturns aren’t the ones with the deepest cuts
August 15, 2023: The Securities and Exchange Commission is examining Illumina over its controversial $7.1 billion purchase of cancer test creator Grail, the DNA sequencing company stated in a security filing on Thursday.
The previous month, the SEC informed Illumina near the probe and requested documents and communications related to the agreement. According to the filing, the agency also asked for statements and disclosures about the “conduct and compensation” of certain Illumina and Grail management members.
Shares of Illumina decreases by 4% on Friday.
The SEC’s probe only stresses Illumina, which has lost significant sums since closing the deal in August 2021. The company’s market value has decreased to roughly $28 billion from around $75 billion the month the agreement closed.
Illumina’s Grail deal has also met heavy scrutiny from U.S. and European Union antitrust regulators.
The European Commission, the EU’s executive body, fined Illumina a record $476 million in the previous month for closing the acquisition without first securing regulatory approval.
The fine came after the commission stopped the deal in September over concerns it would stifle innovation and consumer choice in the emerging market for cancer detection tests.
Illumina has appealed the European Commission’s decision, arguing that the body lacks jurisdiction to block the merger between the two U.S. firms.
Illumina expects a final decision on an appeal in late 2023 or early 2024. That’s also when the company anticipates it will hear an outcome of its appeal of a similar order by the U.S. Federal Trade Commission.
Illumina has stated that it will divest Grail if it loses either request.
Illumina’s conclusion to keep Grail sparked a heated representative showdown with activist investor Carl Icahn, who holds a 1.4% stake in the company.
Illumina thinks it can expand Grail’s Galleri test’s availability, affordability, and profitability, which can screen for over 50 types of cancers through a single blood draw.
But the CEOs who make history in downturns aren’t the ones with the deepest cuts
Companies invest millions in leadership development, yet many of their best executives leave within a few years. Why?
The most successful business leaders don’t just identify gaps in the market; they anticipate future needs before anyone else.
With technological advancements, shifting consumer expectations, and global interconnectedness, the role of business leaders
The leadership landscape is profoundly changing, influenced by technological advancements, shifting workforce expectations, and the need for adaptability in an unpredictable global environment.
In the fast-paced business world, corporate leaders often find themselves at the crossroads of risk and reward, where bold decisions …
April 24, 2025: Silicon Valley is experiencing a sharp recalibration in artificial intelligence investment, with signs of AI fatigue emerging across venture capital
April 23, 2025: The Canadian government has introduced new legislation to regulate the use of artificial intelligence in education and healthcare, focusing on accountability,
April 17, 2025: Prime Minister Justin Trudeau s government is under growing political pressure over its current immigration strategy.
But the CEOs who make history in downturns aren’t the ones with the deepest cuts
Leave us a message
Subscribe
Fill the form our team will contact you
Advertise with us
Fill the form our team will contact you
